Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy

Kidney International

Volumn 68, Issue 1, 2005, Pages 302-310

  Kuroki, Aki ^a   Iyoda, Masayuki ^a   Shibata, Takanori ^a   Sugisaki, Tetsuzo ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Cytokines; Idiopathic membranous nephropathy; IgG4; Peripheral lymphocytes

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNE RESPONSE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; T LYMPHOCYTE; TH2 CELL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANTIGENS, CD19; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; B-LYMPHOCYTES; CYTOKINES; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; MALE; MIDDLE AGED; RNA, MESSENGER; TH2 CELLS;

EID: 24944570216     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00415.x     Document Type: Article

References (40)

1. KERJASCHKI D, FARQUHAR MG: The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal brush border. Proc Natl Acad Sci USA 79:5557-5561, 1982
2. SAITO A, PIETROMONACO S, LOOK AK, FARQUHAR MG: Complete cloning and sequence of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA 91:9725-9729, 1994
3. ORLANDO RA, KERJASCHKI D, FARQUHAR MG: Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein. J Am Soc Nephrol 6:61-67, 1995
4. SALANT D, BELOK S, MADAIO MP, COUSER WG: A new role for complement in experimental membranous nephropathy in rat. J Clin Invest 66:1339-1350, 1980
5. COUSER WG, SCHULZE M, PRUCHNO CJ: Role of C5b-9 in experimental membranous nephropathy. Nephrol Dial Transplant (Suppl 1):25-31, 1992
6. SHANKLAND JS, FLOEGE J, THOMAS SE, et al: Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52:404-423, 1997
7. CYBULSKY AV, PAPILLON J, MCTAVISH AJ: Complement activates phospholipases and protein kinase in glomerular epithelial cells. Kidney Int 54:360-372, 1998
8. SHANKLAND JS, PIPPIN JW, COUSER WG: Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro. Kidney Int 56:538-548, 1999
9. 2 activation in experimental membranous nephropathy. Kidney Int 57:1052-1062, 2000
10. CHATENOUD L, BACH MA: Abnormalities of T-cell subsets in glomerulonephritis and systemic lupus erythematosus. Kidney Int 20:267-274, 1981
11. CAGNOLI L, TABBACHI P, PASQUALI S, et al: T cell subset alterations in idiopathic glomerulonephritis. Clin Exp Immunol 50:70-76, 1982
12. BANNISTER KM, DREW PA, CLARKSON AR, WOODROFFE AJ: Immunoregulation in glomerulonephritis. Henoch-Schonlein purpura and lupus nephritis. Clin Exp Immunol 53:384-390, 1983
13. ROTHSCHILD E, CHATENOUD L: T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritis. Kidney Int 25:557-564, 1984
14. ZUCCHELLI P, PONTICELLI C, CAGNOLI L, et al: Prognostic value of T lymphocytes subset ratio in idiopathic membranous nephropathy. Am J Nephrol 8:15-20, 1988
15. OZAKI T, TOMINO Y, NAKAYAMA S: Two-color analysis of lymphocyte subpopulations in patients with nephrotic syndrome due to membranous nephropathy. Clin Nephrol 38:75-80, 1992
16. OOI BS, OOI YM, HSU A, HURTUBISE E: Diminished synthesis of immunoglobulin by peripheral lymphocytes of patients with idiopathic membranous glomerulonephropathy. J Clin Invest 65:789-797, 1980
17. TAUBE D, BROWN Z, WILLIAMS DG: Impaired lymphocyte and suppressor cell function in minimal change nephropathy, membranous nephropathy and focal glomerulosclerosis. Clin Nephrol 22:176-182, 1984
18. HIRAYAMA K, EBIHARA I, YAMAMOTO S, et al: Predominance of type-2 immune response in idiopathic membranous nephropathy. Nephron 91:255-261, 2002
19. MASUTANI K, TANIGUCHI M, NAKASHIMA H, et al: Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy. Nephrol Dial Transplant 19:580-586, 2004
20. DOI T, MAYUMI M, KANATSU K, et al: Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 58:57-62, 1984
21. IMAI H, HAMAI K, KOMATSUDA A, et al: IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 51:270-276, 1997
22. KUROKI A, SHIBATA T, HONDA H, et al: Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 41:936-942, 2002
23. OHTANI H, WAKUI H, KOMATSUDA A, et al: Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 19:574-579, 2004
24. DOI T, KANATSU K, MAYUMI M, et al: Analysis of IgG immune complexes in sera from patients with membranous nephropathy: Role of IgG4 subclass and low avidity antibodies. Nephron 57:131-136, 1991
25. EKERFELT C, ERNERUDH J, JENMALM MC: Detection of spontaneous and antigen-induced human interleukin-4 responses in vitro: Comparison of ELISPOT, a novel ELISA and real-time RT-PCR. J Immunol Methods 260:55-67, 2002
26. KLEIN U, RAJEWSKI K, KUPPERS R: Human immunoglobulin IgM + IgD + peripheral B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 188:1679-1689, 1998
27. KINDLER V, ZUBLER R: Memory, but not naïve, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-13. J Immunol 159:2085-2090, 1997
28. FECTEAU JF, NERON S: CD40 stimulation of human peripheral B lymphocytes: Distinct response from naïve and memory cells. J Immunol 171:4621-4629, 2003
29. AGEMATSU K, HORIBARA S, NAGUMO H, KOMIYAMA A: CD27: A memory B-cell marker. Immunol Today 21:204-206, 2000
30. REMUZZI G, CHIURCHIU C, ABBATE M, et al: Rituximab for idiopathic membranous nephropathy. Lancet 360:923-924, 2002
31. RUGGENENTI P, CHIURCHIU C, BRUSEGAN V, et al: Rituximab in idiopathic membranous nephropathy: A one year prospective study. J Am Soc Nephrol 14:1851-1857, 2003
32. DEBEIC H, GUIGONIS V, MOUGENOT B, et al: Antinatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053-2060, 2002
33. PARKES AB, MCLACHLAN SN, BIRD P, REESSMITH B: The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol 57:239-243, 1984
34. VINCENT A, MCCONVILLE J, FARRUGIA ME, et al: Antibodies in myasthenia gravis and related disorders. Ann NY Acad Sci 998:324-335, 2003
35. AYATOLLAHI M, JOUBEH S, MORTAZAVI H, et al: IgG4 as the predominant autoantibody in sera from patients with active state of pemphigus vulgaris. J Eur Acad Dermatol Venereol 18:241-242, 2004
36. BOWMAN C, AMBRUS K, LOCKWOOD CM: Restriction of human IgG subclass expression in the population of auto-antibodies to glomerular basement membrane. Clin Exp Immunol 69:341-349, 1987
37. AALBERSE RC, VAN DER GAAG R, VAN LEEUWEN J: Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 130:722-726, 1983
38. GEHLHAR K, SCHLAAK M, BECKER W, BUFE A: Monitoring allergen immunotherapy of pollen-allergic patients: The ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy 29:497-506, 1999
39. ISKANDER R, DAS PK, AALBERSE RC: IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol 66:200-207, 1981
40. YASUMOTO K, DOYLE C, MIELE L, GERMAIN RN: The duration of antigen receptor signaling determines CD4+ versus CD8+ T-cell lineage fate. Nature 404:506-510, 2000